文献速递乳房整形与再造

胸肌前乳房再造较胸肌下再造减少乳房切除术后阿片类药物消耗与疼痛:头对头比较

Prepectoral Breast Reconstruction Reduces Opioid Consumption and Pain After Mastectomy: A Head-to-Head Comparison With Submuscular Reconstruction.
PubMed 文献 · Ann Plast Surg · 2022-09-09

该回顾性图表综述纳入2012至2019年由同一整形外科医生完成的211例胸肌下和117例胸肌前组织扩张器即刻乳房再造患者,比较术后阿片类药物用量与疼痛评分。胸肌下组术后阿片类药物用量更高(80.0 vs 45.0 口服吗啡当量,P < 0.001),住院期间最高疼痛评分也更高(7/10 vs 5/10,P < 0.004)。作者结论为胸肌前再造与更少阿片类药物消耗和更低疼痛评分相关,但需未来随机对照试验进一步研究。

要点

  • 胸肌下再造术后阿片类药物用量高于胸肌前(80.0 vs 45.0 口服吗啡当量,P < 0.001)。
  • 胸肌下再造住院期间最高疼痛评分高于胸肌前(7/10 vs 5/10,P < 0.004)。
  • 多变量线性回归提示乳房切除类型和胸肌下再造是术后阿片类药物使用的显著影响因素(P < 0.05)。

核心结论

  • 在控制其他手术和麻醉因素后,胸肌前乳房再造与较少的术后阿片类药物消耗和较低的术后疼痛评分相关。

研究设计与样本

  • 回顾性图表综述,纳入2012至2019年由同一整形外科医生完成的即刻组织扩张器乳房再造患者,共211例胸肌下和117例胸肌前再造患者。

主要发现

  • 胸肌下再造患者术后阿片类药物用量高于胸肌前再造患者(80.0 vs 45.0 口服吗啡当量,P < 0.001)。
  • 胸肌下再造患者住院期间最高疼痛评分高于胸肌前再造患者(7/10 vs 5/10,P < 0.004)。
  • 多变量线性回归提示乳房切除类型和胸肌下再造是术后阿片类药物使用的显著影响因素(P < 0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute pain after mastectomy is increased with concurrent breast reconstruction. One postulated advantage of prepectoral breast reconstruction is less postoperative pain; however, no comparisons to partial submuscular reconstruction have been made to date. Here, we examined the postoperative pain experienced between patients with prepectoral and subpectoral breast reconstruction after mastectomy. METHODS: We performed a retrospective chart review of all patients undergoing immediate breast reconstruction with tissue expanders from 2012 to 2019 by a single plastic surgeon. Patient demographics, surgical details, and anesthetic techniques were evaluated, and our primary outcome compared postoperative opioid usage between prepectoral and subpectoral reconstructions. Our secondary outcome compared pain scores between techniques. RESULTS: A total of 211 subpectoral and 117 prepectoral reconstruction patients were included for analysis. Patients with subpectoral reconstructions had higher postoperative opioid usage (80.0 vs 45.0 oral morphine equivalents, P < 0.001). Subpectoral patients also recorded higher maximum pain scores compared with prepectoral reconstructions while admitted (7 of 10 vs 5 of 10, P < 0.004). Multivariable linear regression suggests that mastectomy type and subpectoral reconstruction were significant contributors to postoperative opioid use (P < 0.05). CONCLUSIONS: Prepectoral breast reconstruction was associated with less postoperative opioid consumption and lower postoperative pain scores as compared with subpectoral reconstruction, when controlling for other surgical and anesthesia factors. Future randomized controlled trials are warranted to study how postoperative pain and chronic pain are influenced by the location of prosthesis placement in implant-based postmastectomy breast reconstruction.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Holland M, Su P, Piper M, et al. Prepectoral Breast Reconstruction Reduces Opioid Consumption and Pain After Mastectomy: A Head-to-Head Comparison With Submuscular Reconstruction. Ann Plast Surg. 2022. PMID: 36279573. doi:10.1097/SAP.0000000000003271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。